دورية أكاديمية

Synthesis, characterization and anti-diabetic therapeutic potential of novel aminophenol-derivatized nitrilotriacetic acid vanadyl complexes

التفاصيل البيبلوغرافية
العنوان: Synthesis, characterization and anti-diabetic therapeutic potential of novel aminophenol-derivatized nitrilotriacetic acid vanadyl complexes
المؤلفون: Wang, Na, Wang, Ziwei, Niu, Xia, Yang, Xiaoda
المساهمون: Yang, XD (reprint author), Peking Univ, Sch Pharmaceut Sci, Dept Biol Chem, Hlth Sci Ctr,State Key Labs Nat & Biomimet Drugs, Beijing 100191, Peoples R China., Peking Univ, Sch Pharmaceut Sci, Dept Biol Chem, Hlth Sci Ctr,State Key Labs Nat & Biomimet Drugs, Beijing 100191, Peoples R China.
المصدر: PubMed ; SCI
بيانات النشر: JOURNAL OF INORGANIC BIOCHEMISTRY
سنة النشر: 2015
المجموعة: Peking University Institutional Repository (PKU IR) / 北京大学机构知识库
مصطلحات موضوعية: Vanadium, Diabetes, Aminophenol, PPAR alpha, PPAR gamma, INSULIN-MIMETIC AGENT, OXIDATIVE STRESS, VANADIUM(IV) COMPLEXES, DIABETIC-RATS, PPAR-GAMMA, CHEMISTRY, ACTIVATION, CELLS, OXIDOVANADIUM(IV), MECHANISMS
الوصف: In the present work, we synthesized three novel aminophenol-derivatized nitrilotriacetic acid vanadyl complexes (VOohpada, VOmhpada, VOphpada) using the strategy of rational incorporation of antioxidant groups in ligand in order to balance the side effects with the therapeutic properties. The complexes were characterized by IR, UV-VIS, ESI-MS and elemental analysis. The biological evaluations in vitro revealed that the position of the hydroxyl group of aminophenol moiety regulated the antioxidant activity of the complexes as well as the cytotoxicity on HK-2 cells. The vanadyl complex of p-hydroxyl aminophenol derivative (VOphpada) exhibited better antioxidant activity and lower cytotoxicity than other analogs. In type II diabetic db/db mice, VOphpada (0.1 mmol/kg/day) effectively reduced blood glucose level, improved glucose tolerance, and alleviated stresses induced by hyperglycemia and hyperlipidemia. VOphpada treatment significantly increased expression of PPARa and activated Akt, and inactivated JNK in muscle and adipose tissues. The insulin enhancement effects of VOphpada were observed more potent than BMOV. Moreover, VOphpada decreased the level of kidney injury molecule-1 marker (KIM-1), suggesting a potentially lower renal toxicity. In overall, the present results suggest VOphpada as a novel hypoglycemic agent with improved efficacy-over-toxicity index. (C) 2015 Elsevier Inc. All rights reserved. ; NNSFC [21271012] ; SCI(E) ; PubMed ; ARTICLE ; xyang@bjmu.edu.cn ; SI ; 104-113 ; 152
نوع الوثيقة: journal/newspaper
اللغة: English
تدمد: 0162-0134
1873-3344
العلاقة: JOURNAL OF INORGANIC BIOCHEMISTRY.2015,152,(,SI),104-113.; 1297117; http://hdl.handle.net/20.500.11897/418024Test; WOS:000367127800010
DOI: 10.1016/j.jinorgbio.2015.07.012
الإتاحة: https://doi.org/20.500.11897/418024Test
https://doi.org/10.1016/j.jinorgbio.2015.07.012Test
https://hdl.handle.net/20.500.11897/418024Test
رقم الانضمام: edsbas.21FEE72F
قاعدة البيانات: BASE
الوصف
تدمد:01620134
18733344
DOI:10.1016/j.jinorgbio.2015.07.012